SDS

Version: 3.1
Revision Date: 10/12/2018
000000016967
11/18
Information on toxicological effects
Acute toxicity (list all possible routes of exposure)
Oral
Product:
ATEmix: 138,552.24 mg/kg
Dermal
Product:
ATEmix: 11,135.34 mg/kg
Inhalation
Product:
Not classified for acute toxicity based on available data.
Repeated dose toxicity
Product:
No data available.
Skin Corrosion/Irritation
Product:
No data available.
Serious Eye Damage/Eye Irritation
Product:
No data available.
Respiratory or Skin Sensitization
Product:
May cause allergy or asthma symptoms or breathing difficulties if inhaled.
May cause sensitization by inhalation.
Carcinogenicity
Product:
No data available.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans:
Titanium dioxide Overall evaluation: Possibly carcinogenic to humans.
Ethylbenzene
Overall evaluation: Possibly carcinogenic to humans.
Hydrotreated heavy
naphthenic distillate
Overall evaluation: Not classifiable as to carcinogenicity to humans. Overall
evaluation: Carcinogenic to humans.
US. National Toxicology Program (NTP) Report on Carcinogens:
Hydrotreated heavy
naphthenic distillate
Known To Be Human Carcinogen.
US. OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050):
Polyvinyl chloride
Cancer